CVE detail

CVE-2025-15066 — CVE-2025-15066

Published 2025-12-29 · Modified 2026-06-17 · Source nvd

MEDIUM

severity

CVSS-derived band

6.2

CVSS v3

0–10 scale

0.0014

EPSS probability

exploitation probability, 30d

4.0%

EPSS percentile

percentile vs all CVEs

NOT LISTED

CISA KEV

known exploited catalog

Description

Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal'), Missing Authorization vulnerability in Innorix WP allows Path Traversal.This issue affects Innorix WP from All versions If the "exam" directory exists under the directory where the product is installed (ex: innorix/exam)

Remediation

No vendor-published fix data in our corpus for this CVE. Check the references below or the vendor's PSIRT / security advisories page.

References

cvedb.io · NVD · CISA KEV · FIRST EPSS · vendor advisories (CVE Program List v5). Informational only, no warranty — verify every remediation against the vendor advisory before acting on it. This product uses data from the NVD API but is not endorsed or certified by the NVD, CISA, FIRST.org or any vendor named. CVE® is a registered trademark of The MITRE Corporation.